What is the recommended dose of N-acetylcysteine (NAC) for a patient with acute hepatic dysfunction likely due to acetaminophen overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NAC Dosing for Acute Hepatic Dysfunction from Acetaminophen Overdose

For acute hepatic dysfunction from acetaminophen overdose, administer IV N-acetylcysteine at 150 mg/kg over 15 minutes, followed by 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours (total 21-hour protocol), and continue beyond 21 hours if acetaminophen remains detectable or transaminases continue rising. 1, 2, 3

Standard IV NAC Protocol

The FDA-approved intravenous regimen consists of three sequential doses totaling 300 mg/kg over 21 hours 3:

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes 1, 3
  • Second dose: 50 mg/kg over 4 hours 1, 3
  • Third dose: 100 mg/kg over 16 hours 1, 3

Alternatively, oral NAC can be administered as 140 mg/kg loading dose followed by 70 mg/kg every 4 hours for 17 doses (72-hour protocol), though IV is preferred in established hepatic failure 1, 2.

Critical Management in Established Hepatic Failure

When hepatic failure is already present, NAC must be administered immediately regardless of time since ingestion, as it reduces mortality from 80% to 52%. 1, 2 This represents a Level B recommendation from the American College of Emergency Physicians 2.

Key benefits in fulminant hepatic failure include 2:

  • Mortality reduction from 80% to 52%
  • Cerebral edema reduction from 68% to 40%
  • Decreased need for inotropic support from 80% to 48%

Extended Treatment Beyond 21 Hours

Do not stop NAC at 21 hours if any of the following are present 2, 3:

  • Detectable acetaminophen levels
  • Rising or elevated transaminases (AST/ALT)
  • Elevated INR or coagulopathy
  • Clinical signs of hepatotoxicity

The FDA label explicitly states: "If acetaminophen levels are still detectable, or if the ALT/AST are still increasing or the INR remains elevated; dosing should be continued" 3. In massive overdoses or with co-ingestions, the standard 21-hour protocol is often insufficient 1, 4, 5.

For continued therapy, contact poison control (1-800-222-1222) or the acetaminophen overdose assistance line (1-800-525-6115) for dosing guidance 3.

Monitoring Requirements

Throughout treatment, monitor 2, 3:

  • Acetaminophen levels (repeat if initially elevated)
  • AST/ALT (check after each dosing phase)
  • INR/PT (coagulation status)
  • Creatinine and BUN (renal function)
  • Electrolytes and blood glucose

Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with acetaminophen poisoning and should prompt NAC treatment even without confirmatory history. 2

Special Considerations for Acute Liver Failure

In patients presenting with established acute liver failure 1, 2:

  • Initiate NAC immediately without waiting for confirmatory acetaminophen levels
  • Low or absent acetaminophen levels do NOT rule out acetaminophen poisoning if ingestion was remote
  • Contact liver transplant center immediately for any evidence of liver failure
  • ICU-level care required for severe hepatotoxicity (AST >1,000 IU/L) or coagulopathy

High-Risk Populations Requiring Lower Treatment Threshold

Patients with chronic alcohol use should receive NAC even with acetaminophen levels in the "non-toxic" range, as severe hepatotoxicity can occur with doses as low as 4 g/day in alcoholics 2. Other high-risk groups include fasting patients and those on enzyme-inducing drugs 2.

Common Pitfalls

  • Never delay NAC while awaiting confirmatory levels if there is strong suspicion of significant overdose 2
  • The Rumack-Matthew nomogram does NOT apply to patients presenting >24 hours after ingestion or with repeated supratherapeutic ingestions 2
  • Standard 21-hour protocols may be inadequate in massive overdoses (initial levels >400 mg/L), combination product ingestions, or extended-release formulations 4, 5
  • Activated charcoal can be given just prior to NAC if patient presents within 4 hours, but should not delay NAC administration 2

Oral vs. IV NAC Efficacy

While both routes are effective, modeling studies suggest the 72-hour oral protocol may preserve more hepatocytes than the 21-hour IV protocol, particularly in delayed presentations 6. However, IV NAC is preferred in established hepatic failure due to concerns about absorption and the need for reliable delivery 1.

References

Guideline

N-Acetylcysteine Administration in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2009

Related Questions

What is the treatment algorithm for a patient with acetaminophen (N-acetylcysteine) overdose, particularly those with a history of liver disease or chronic alcohol use, presenting with potential liver damage and impaired liver function tests, including elevated Alanine Transaminase (ALT) and Aspartate Transaminase (AST) levels?
What is the recommended dosage of N-acetyl cysteine (NAC) for the treatment of hepatitis?
What is the recommended IV dose of N-acetyl-cysteine (NAC) for a 68kg patient with paracetamol intoxication?
What is the specific antidote for acetaminophen (N-acetylcysteine) intoxication?
What is the recommended dosing regimen for N-acetylcysteine (NAC) in acetaminophen overdose?
What is the recommended treatment for a patient with a positive Rapid Plasma Reagin (RPR) test result indicating syphilis?
Should a patient with microcytic anemia, as indicated by a Mean Corpuscular Volume (MCV) of 71.4, Mean Corpuscular Hemoglobin (MCH) of 21.4, Mean Corpuscular Hemoglobin Concentration (MCHC) of 30.0, and Red Cell Distribution Width (RDW) of 15.7, be started on oral iron supplements?
What are the contraindications for initiating Acetylsalicylic Acid (ASA) load therapy in patients?
What is the initial treatment approach for a patient presenting with a cough, considering their age, medical history, and current medications, including conditions such as asthma or Chronic Obstructive Pulmonary Disease (COPD)?
What is the appropriate management for a pediatric patient presenting with signs of peritoneal irritation?
Can inulin be used as a treatment for a patient with fatty liver disease (steatosis), and what is the recommended dosage?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.